Skip to main content

Multiple System Atrophy clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • GDNF Gene Therapy for Multiple System Atrophy

    Sorry, not yet accepting patients

    The objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a possible or probable diagnosis of Multiple System Atrophy.

    Irvine, California and other locations

Last updated: